Clinical impact of HLA class I expression in rectal cancer
β Scribed by Frank M. Speetjens; Elza C. de Bruin; Hans Morreau; Eliane C. M. Zeestraten; Hein Putter; J. Han van Krieken; Maaike M. van Buren; Monique van Velzen; N. Geeske Dekker-Ensink; Cornelis J. H. van de Velde; Peter J. K. Kuppen
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 486 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Loss of surface expression of class I major histocompatibility antigens is commonly observed in malignant tumors and has been considered one of the mechanisms for escape from cytotoxic T cells. However, natural killer cells kill cells lacking HLA class I antigens. In the present study, we characteri
HLA class-I expression has been investigated by biochemical methods in 14 Burkitt lymphoma (BL) cell lines and the corresponding Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) derived from the same individuals. Selective down-regulation of one or more HLA class-I specificities